Derivation of human embryonic stem cells in defined conditions
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
We have previously reported that high concentrations of basic fibroblast growth factor (bFGF) support feeder-independent growth of human embryonic stem (ES) cells, but those conditions included poorly defined serum and matrix components. Here we report feeder-independent human ES cell culture that includes protein components solely derived from recombinant sources or purified from human material. We describe the derivation of two new human ES cell lines in these defined culture conditions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since the discovery of iPSC generation, the field has transitioned from using PSC culture media containing animal reagents to Xeno-free and even animal-free media [64,65,66].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [66]
Citations
Cites
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Self-citationYing, Q.-L., Nichols, J., Chambers, I., & Smith, A. (2003) · Cell · doi:10.1016/s0092-8674(03)00847-x · Cited by 2,122
Sato, N., Meijer, L., Skaltsounis, L., Greengard, P., & Brivanlou, A. H. (2004) · Nature Medicine · doi:10.1038/nm979 · Cited by 2,109
Amit, M., Carpenter, M. K., Inokuma, M. S., Chiu, C.-P., Harris, C. P., Waknitz, M. A., Itskovitz-Eldor, J., & Thomson, J. A. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9912 · Cited by 1,472
Self-citationBMP4 initiates human embryonic stem cell differentiation to trophoblast
Xu, R.-H., Chen, X., Li, D. S., Li, R., Addicks, G. C., Glennon, C., Zwaka, T. P., & Thomson, J. A. (2002) · Nature Biotechnology · doi:10.1038/nbt761 · Cited by 1,128
Self-citationRecurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells
Draper, J. S., Smith, K., Gokhale, P., Moore, H. D., Maltby, E., Johnson, J., Meisner, L., Zwaka, T. P., Thomson, J. A., & Andrews, P. W. (2004) · Nature Biotechnology · doi:10.1038/nbt922 · Cited by 1,021
Self-citationBasic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells
Xu, R.-H., Peck, R. M., Li, D. S., Feng, X., Ludwig, T., & Thomson, J. A. (2005) · Nature Methods · doi:10.1038/nmeth744 · Cited by 973
Self-citationHuman embryonic stem cells express an immunogenic nonhuman sialic acid
Martin, M. J., Muotri, A., Gage, F., & Varki, A. (2005) · Nature Medicine · doi:10.1038/nm1181 · Cited by 932
Feeder Layer- and Serum-Free Culture of Human Embryonic Stem Cells1
Amit, M., Shariki, C., Margulets, V., & Itskovitz-Eldor, J. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.103.021147 · Cited by 664
Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors
Sperger, J. M., Chen, X., Draper, J. S., Antosiewicz, J. E., Chon, C. H., Jones, S. B., Brooks, J. D., Andrews, P. W., Brown, P. O., & Thomson, J. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235735100 · Cited by 648
Self-citation
Cited by
Human DNA methylomes at base resolution show widespread epigenomic differences
Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., Nery, J. R., Lee, L., Ye, Z., Ngo, Q.-M., et al. (2009) · Nature · doi:10.1038/nature08514 · Cited by 4,673
Self-citationDirected differentiation of human pluripotent stem cells into intestinal tissue in vitro
Spence, J. R., Mayhew, C. N., Rankin, S. A., Kuhar, M. F., Vallance, J. E., Tolle, K., Hoskins, E. E., Kalinichenko, V. V., Wells, S. I., Zorn, A. M., et al. (2011) · Nature · doi:10.1038/nature09691 · Cited by 1,922
Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells
Lister, R., Pelizzola, M., Kida, Y. S., Hawkins, R. D., Nery, J. R., Hon, G., Antosiewicz-Bourget, J., O’Malley, R., Castanon, R., Klugman, S., et al. (2011) · Nature · doi:10.1038/nature09798 · Cited by 1,549
Self-citationSialic acids in human health and disease
Varki, A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.06.002 · Cited by 999
“The implications of this Neu5Gc contamination are still being investigated [41].”
Distinct epigenomic landscapes of pluripotent and lineage-committed human cells
Hawkins, R. D., Hon, G. C., Lee, L. K., Ngo, Q., Lister, R., Pelizzola, M., Edsall, L. E., Kuan, S., Luu, Y., Klugman, S., et al. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.03.018 · Cited by 806
Self-citationThe therapeutic potential of neural stem cells
Martino, G., & Pluchino, S. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1908 · Cited by 744
Whole-Genome Analysis of Histone H3 Lysine 4 and Lysine 27 Methylation in Human Embryonic Stem Cells
Pan, G., Tian, S., Nie, J., Yang, C., Ruotti, V., Wei, H., Jonsdottir, G. A., Stewart, R., & Thomson, J. A. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.003 · Cited by 711
“…Cell Stem Cell 1, 299–312, September 2007 ª2007 Elsevie matin immunoprecipitation, ChIP) from H1 human ES cells maintained in defined medium (TeSR medium), (Figure 1A and see Figure S1A in the Supplemental Data available with this article online) (Ludwig et al., 2006a; Ludwig et al., 2006b).”
BackgroundSelf-citationFeeder-independent culture of human embryonic stem cells
Ludwig, T. E., Bergendahl, V., Levenstein, M. E., Yu, J., Probasco, M. D., & Thomson, J. A. (2006) · Nature Methods · doi:10.1038/nmeth902 · Cited by 681
“, and based on inhibitor studies, it has been suggested that TGFβ/activin signaling is essential for human embryonic stem cell self-renewa”
BackgroundSelf-citationAdaptation to culture of human embryonic stem cells and oncogenesis in vivo
Baker, D. E. C., Harrison, N. J., Maltby, E., Smith, K., Moore, H. D., Shaw, P. J., Heath, P. R., Holden, H., & Andrews, P. W. (2007) · Nature Biotechnology · doi:10.1038/nbt1285 · Cited by 636
“Trisomy X has once been reported as the sole abnormalit”
BackgroundTitin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy
Hinson, J. T., Chopra, A., Nafissi, N., Polacheck, W. J., Benson, C. C., Swist, S., Gorham, J., Yang, L., Schafer, S., Sheng, C. C., et al. (2015) · Science · doi:10.1126/science.aaa5458 · Cited by 638
Isolation, cultivation, and characterization of human mesenchymal stem cells
Mushahary, D., Spittler, A., Kasper, C., Weber, V., & Charwat, V. (2018) · Cytometry Part A · doi:10.1002/cyto.a.23242 · Cited by 599
Bendall, S. C., Stewart, M. H., Menendez, P., George, D., Vijayaragavan, K., Werbowetski-Ogilvie, T., Ramos-Mejia, V., Rouleau, A., Yang, J., Bossé, M., et al. (2007) · Nature · doi:10.1038/nature06027 · Cited by 588
Wnt signaling and stem cell control
Nusse, R. (2008) · Cell Research · doi:10.1038/cr.2008.47 · Cited by 585
Li, W., Wei, W., Zhu, S., Zhu, J., Shi, Y., Lin, T., Hao, E., Hayek, A., Deng, H., & Ding, S. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2008.11.014 · Cited by 567
“…Wnt signaling seems to contribute favorably to self-renewal of both mESCs and hESCs when combined with appropriate modulation of other pathways (Ludwig et al., 2006; Umehara et al., 2007) Therefore, we supplemented the standard mESC conditions with a combination of a MEK inhibitor (0.5 mM…”
InfluentialAnimal‐cell culture media: History, characteristics, and current issues
Yao, T., & Asayama, Y. (2017) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12024 · Cited by 536
“The cultures require feeder cells TeSR (Ludwig et al. 2006) DMEM/F- 12 Vitamins, trace elements (V, Mn, Ni, Si, Sn, Mo, Cd, Cr, Ag, Al, Ba, Co, Ge, Br, I, F, Rb, Zr), selenite, LiCl, insulin, transferrin, human serum albumin (HSA), bFGF, transforming growth factor (TGF)- β1, γ- aminobutyric acid, pipecolic acid, gluta…”
Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511
Rodin, S., Domogatskaya, A., Ström, S., Hansson, E. M., Chien, K. R., Inzunza, J., Hovatta, O., & Tryggvason, K. (2010) · Nature Biotechnology · doi:10.1038/nbt.1620 · Cited by 553
“Matrix proteins have been used as coating substrata for in vitro cultures of hES cells in numerous studies, but they have usually been applied as undefined protein mixture”
MethodCombinatorial development of biomaterials for clonal growth of human pluripotent stem cells
Mei, Y., Saha, K., Bogatyrev, S. R., Yang, J., Hook, A. L., Kalcioglu, Z. I., Cho, S.-W., Mitalipova, M., Pyzocha, N., Rojas, F., et al. (2010) · Nature Materials · doi:10.1038/nmat2812 · Cited by 544
Human embryonic stem cell lines derived from single blastomeres
Klimanskaya, I., Chung, Y., Becker, S., Lu, S.-J., & Lanza, R. (2006) · Nature · doi:10.1038/nature05142 · Cited by 522
NANOG Is a Direct Target of TGFβ/Activin-Mediated SMAD Signaling in Human ESCs
Xu, R.-H., Sampsell-Barron, T. L., Gu, F., Root, S., Peck, R. M., Pan, G., Yu, J., Antosiewicz-Bourget, J., Tian, S., Stewart, R., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.001 · Cited by 511
Self-citationHuman pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations
Merkle, F. T., Ghosh, S., Kamitaki, N., Mitchell, J., Avior, Y., Mello, C., Kashin, S., Mekhoubad, S., Ilic, D., Charlton, M., et al. (2017) · Nature · doi:10.1038/nature22312 · Cited by 506
Fetal Bovine Serum (FBS): past ‐ present ‐ future
van der Valk, J. (2018) · ALTEX · doi:10.14573/altex.1705101 · Cited by 481
“) for serum-free culture of human embryonic (hESC) and induced pluripotent (hiPSC) stem cells is supplemented with human serum albumin, human holo-transferrin and human insulin (Ludwig et al., 2006).”
MethodYao, S., Chen, S., Clark, J., Hao, E., Beattie, G. M., Hayek, A., & Ding, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602280103 · Cited by 453
Braam, S. R., Zeinstra, L., Litjens, S., Ward-van Oostwaard, D., van den Brink, S., van Laake, L., Lebrin, F., Kats, P., Hochstenbach, R., Passier, R., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0291 · Cited by 432
Melkoumian, Z., Weber, J. L., Weber, D. M., Fadeev, A. G., Zhou, Y., Dolley-Sonneville, P., Yang, J., Qiu, L., Priest, C. A., Shogbon, C., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1629 · Cited by 445
Forristal, C. E., Wright, K. L., Hanley, N. A., Oreffo, R. O. C., & Houghton, F. D. (2010) · Reproduction · doi:10.1530/rep-09-0300 · Cited by 396
“Reproduction (2010) 139 85–97”
BackgroundMethodResultInfluentialChan, Y.-S., Göke, J., Ng, J.-H., Lu, X., Gonzales, K. A. U., Tan, C.-P., Tng, W.-Q., Hong, Z.-Z., Lim, Y.-S., & Ng, H.-H. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.11.015 · Cited by 393
Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development
Karagiannis, P., Takahashi, K., Saito, M., Yoshida, Y., Okita, K., Watanabe, A., Inoue, H., Yamashita, J. K., Todani, M., Nakagawa, M., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00039.2017 · Cited by 368
Lengner, C. J., Gimelbrant, A. A., Erwin, J. A., Cheng, A. W., Guenther, M. G., Welstead, G. G., Alagappan, R., Frampton, G. M., Xu, P., Muffat, J., et al. (2010) · Cell · doi:10.1016/j.cell.2010.04.010 · Cited by 397
“, 2006), protection against spontaneous differentiation, enhanced efficiency of cloning (Ezashi et al., 2005; Forsyth et al., 2008; Ludwig et al., 2006; Prasad et al., 2009), and direct epigenetic reprogramming (Yoshida et al.”
BackgroundSingh, A. M., Reynolds, D., Cliff, T., Ohtsuka, S., Mattheyses, A. L., Sun, Y., Menendez, L., Kulik, M., & Dalton, S. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.01.014 · Cited by 356
“Sources of Activin A include MEF feeder layers, MEF-CM in addition to its inclusion in defined media formulations (Ludwig et al., 2006; Wang et al., 2007; Yao et al., 2006).”
BackgroundArmstrong, L., Hughes, O., Yung, S., Hyslop, L., Stewart, R., Wappler, I., Peters, H., Walter, T., Stojkovic, P., Evans, J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl112 · Cited by 365
“A recent paper described the successful use of g-aminobutyric acid and pipecolic acid which enhances GABA A receptor responses together with FGF2, LiCl2 and TGFb in defined medium to grow and derive new hESC lines (42).”
BackgroundMethodChowdhury, F., Li, Y., Poh, Y.-C., Yokohama-Tamaki, T., Wang, N., & Tanaka, T. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015655 · Cited by 341
“It remains to be seen if our findings and the underlying biophysical mechanism on mESCs can be extended to hESCs and iPSCs since recent advances in defining culture conditions chemically are not sufficient to prevent spontaneous differentiation of hESCs [50].”
BackgroundBeers, J., Gulbranson, D. R., George, N., Siniscalchi, L. I., Jones, J., Thomson, J. A., & Chen, G. (2012) · Nature Protocols · doi:10.1038/nprot.2012.130 · Cited by 357
Self-citationMultipotent Menstrual Blood Stromal Stem Cells: Isolation, Characterization, and Differentiation
Patel, A. N., Park, E., Kuzman, M., Benetti, F., Silva, F. J., & Allickson, J. G. (2008) · Cell Transplantation · doi:10.3727/096368908784153922 · Cited by 366
Greber, B., Wu, G., Bernemann, C., Joo, J. Y., Han, D. W., Ko, K., Tapia, N., Sabour, D., Sterneckert, J., Tesar, P., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.01.003 · Cited by 354
Miyazaki, T., Futaki, S., Suemori, H., Taniguchi, Y., Yamada, M., Kawasaki, M., Hayashi, M., Kumagai, H., Nakatsuji, N., Sekiguchi, K., et al. (2012) · Nature Communications · doi:10.1038/ncomms2231 · Cited by 368
Synthetic polymer coatings for long-term growth of human embryonic stem cells
Villa-Diaz, L. G., Nandivada, H., Ding, J., Nogueira-de-Souza, N. C., Krebsbach, P. H., O'Shea, K. S., Lahann, J., & Smith, G. D. (2010) · Nature Biotechnology · doi:10.1038/nbt.1631 · Cited by 365
Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics
Chen, K. G., Mallon, B. S., McKay, R. D. G., & Robey, P. G. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2013.12.005 · Cited by 358
“…widely used with FGF-2 to support feeder-based hPSC culture, and a defined culture medium (termed TeSR1) containing FGF-2, lithium chloride (LiCl), g-aminobutyric acid (GABA), TGF-b, and pipeolic acid was developed by Thomson and colleagues for use in feeder-free conditions (Ludwig et al., 2006).”
MethodYu, J., & Thomson, J. A. (2008) · Genes & Development · doi:10.1101/gad.1689808 · Cited by 342
“…likely explains why at high doses of bFGF, exogenous TGF or Activin has only very modest effects on undifferentiated human ES cell proliferation (Ludwig et al. 2006) and, similarly, at sufficient doses of Activin, the beneficial dose of exogenous FGF is greatly reduced (Vallier et al. 2005;…”
BackgroundSelf-citationA chemical approach to stem-cell biology and regenerative medicine
Xu, Y., Shi, Y., & Ding, S. (2008) · Nature · doi:10.1038/nature07042 · Cited by 336
Controlled differentiation of stem cells
Hwang, N. S., Varghese, S., & Elisseeff, J. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.036 · Cited by 325
“Few chemically defined culture conditions have been reported in literature [38,39].”
BackgroundFGF Signaling Pathway: A Key Regulator of Stem Cell Pluripotency
Mossahebi-Mohammadi, M., Quan, M., Zhang, J.-S., & Li, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00079 · Cited by 305
Wang, L., Schulz, T. C., Sherrer, E. S., Dauphin, D. S., Shin, S., Nelson, A. M., Ware, C. B., Zhan, M., Song, C.-Z., Chen, X., et al. (2007) · Blood · doi:10.1182/blood-2007-03-082586 · Cited by 314
Rodin, S., Antonsson, L., Niaudet, C., Simonson, O. E., Salmela, E., Hansson, E. M., Domogatskaya, A., Xiao, Z., Damdimopoulou, P., Sheikhi, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms4195 · Cited by 292
Chen, A. K.-L., Reuveny, S., & Oh, S. K. W. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.03.006 · Cited by 292
“The two commercial media (mTeSR®1 hESC SFM and StemPRO® hESC SFM), are the most robust in terms of long term support of hESCs.”
BackgroundInfluentialCharacterization of human embryonic stem cells with features of neoplastic progression
Werbowetski-Ogilvie, T. E., Bossé, M., Stewart, M., Schnerch, A., Ramos-Mejia, V., Rouleau, A., Wynder, T., Smith, M.-J., Dingwall, S., Carter, T., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1516 · Cited by 278
Biomaterials Approach to Expand and Direct Differentiation of Stem Cells
Chai, C., & Leong, K. W. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300084 · Cited by 284
A defined glycosaminoglycan-binding substratum for human pluripotent stem cells
Klim, J. R., Li, L., Wrighton, P. J., Piekarczyk, M. S., & Kiessling, L. L. (2010) · Nature Methods · doi:10.1038/nmeth.1532 · Cited by 271
“Progress in developing defined conditions for human embryonic stem (hES) cell propagation has resulted from elucidating the roles of soluble factor”
BackgroundSelf-citationGeneration of hepatobiliary organoids from human induced pluripotent stem cells
Wu, F., Wu, D., Ren, Y., Huang, Y., Feng, B., Zhao, N., Zhang, T., Chen, X., Chen, S., & Xu, A. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.028 · Cited by 261
Human embryonic stem cells have a unique epigenetic signature
Bibikova, M., Chudin, E., Wu, B., Zhou, L., Garcia, E. W., Liu, Y., Shin, S., Plaia, T. W., Auerbach, J. M., Arking, D. E., et al. (2006) · Genome Research · doi:10.1101/gr.5319906 · Cited by 271
“Recently efforts have been directed toward development of new culture systems for the maintenance of hES cells in vitro (Ludwig et al. 2006), and such studies potentially represent important technical advances for the field.”
BackgroundDifferentiation of cardiomyocytes and generation of human engineered heart tissue
Breckwoldt, K., Letuffe-Brenière, D., Mannhardt, I., Schulze, T., Ulmer, B., Werner, T., Benzin, A., Klampe, B., Reinsch, M. C., Laufer, S., et al. (2017) · Nature Protocols · doi:10.1038/nprot.2017.033 · Cited by 272
Villa-Diaz, L. G., Ross, A. M., Lahann, J., & Krebsbach, P. H. (2013) · Stem Cells · doi:10.1002/stem.1260 · Cited by 253
Proteomic and phosphoproteomic comparison of human ES and iPS cells
Phanstiel, D. H., Brumbaugh, J., Wenger, C. D., Tian, S., Probasco, M. D., Bailey, D. J., Swaney, D. L., Tervo, M. A., Bolin, J. M., Ruotti, V., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1699 · Cited by 259
“11) in a feeder-independent system, as previously describe”
Self-citationGood manufacturing practice and clinical-grade human embryonic stem cell lines
Unger, C., Skottman, H., Blomberg, P., Sirac Dilber, M., & Hovatta, O. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn079 · Cited by 247
Greber, B., Lehrach, H., & Adjaye, J. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0476 · Cited by 241
Yu, P., Pan, G., Yu, J., & Thomson, J. A. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.01.001 · Cited by 243
“For example, the dominant early phenotypic effect on undifferentiated human ESCs of FGF2 withdrawal is a slowed proliferation (Ludwig et al., 2006b).”
InfluentialSelf-citationRegulation of Apoptosis and Differentiation by p53 in Human Embryonic Stem Cells
Qin, H., Yu, T., Qing, T., Liu, Y., Zhao, Y., Cai, J., Li, J., Song, Z., Qu, X., Zhou, P., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610464200 · Cited by 245
Human Corneal Endothelial Cell Expansion for Corneal Endothelium Transplantation: An Overview
Peh, G. S. L., Beuerman, R. W., Colman, A., Tan, D. T., & Mehta, J. S. (2011) · Transplantation · doi:10.1097/tp.0b013e3182111f01 · Cited by 242
“(89) developed a fully defined, animal product-free culture medium for the derivation, maintenance, expansion, and differentiation of human embryonic stem cells.”
BackgroundDerivation, propagation and controlled differentiation of human embryonic stem cells in suspension
Steiner, D., Khaner, H., Cohen, M., Even-Ram, S., Gil, Y., Itsykson, P., Turetsky, T., Idelson, M., Aizenman, E., Ram, R., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1616 · Cited by 232
Cell type-specific DNA methylation patterns in the human breast
Bloushtain-Qimron, N., Yao, J., Snyder, E. L., Shipitsin, M., Campbell, L. L., Mani, S. A., Hu, M., Chen, H., Ustyansky, V., Antosiewicz, J. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805206105 · Cited by 241
Self-citationPluripotent stem-cell-derived therapies in clinical trial: A 2025 update
Kirkeby, A., Main, H., & Carpenter, M. (2025) · Cell Stem Cell · doi:10.1016/j.stem.2024.12.005 · Cited by 196
Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium
Furue, M. K., Na, J., Jackson, J. P., Okamoto, T., Jones, M., Baker, D., Hata, R.-I., Moore, H. D., Sato, J. D., & Andrews, P. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806136105 · Cited by 238
“ng/ml) (24), and/or members of the TGF- family of growth factors (12, 23), and/or Wnt3A (20) and APRIL/BAFF (29).”
BackgroundLong-term microcarrier suspension cultures of human embryonic stem cells
Oh, S. K. W., Chen, A. K., Mok, Y., Chen, X., Lim, U.-M., Chin, A., Choo, A. B. H., & Reuveny, S. (2009) · Stem Cell Research · doi:10.1016/j.scr.2009.02.005 · Cited by 237
“Recent progress in the development of defined serum-free, feeder-free culture systems (Ludwig et al., 2006; Ding et al., 2006; Chase and Firpo, 2007) provides one part of the solution to a multifaceted puzzle that will enable progress to be made in the production and clinical application of human embryonic stem cells…”
BackgroundThree-dimensional biomaterials for the study of human pluripotent stem cells
Kraehenbuehl, T. P., Langer, R., & Ferreira, L. S. (2011) · Nature Methods · doi:10.1038/nmeth.1671 · Cited by 226
Derivation of a Xeno‐Free Human Embryonic Stem Cell Line
Ellerström, C., Strehl, R., Moya, K., Andersson, K., Bergh, C., Lundin, K., Hyllner, J., & Semb, H. (2006) · STEM CELLS · doi:10.1634/stemcells.2006-0130 · Cited by 209
Heiskanen, A., Satomaa, T., Tiitinen, S., Laitinen, A., Mannelin, S., Impola, U., Mikkola, M., Olsson, C., Miller-Podraza, H., Blomqvist, M., et al. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0444 · Cited by 215
Differences between human embryonic stem cell lines
Allegrucci, C., & Young, L. E. (2007) · Human Reproduction Update · doi:10.1093/humupd/dml041 · Cited by 217
Akhmanova, M., Osidak, E., Domogatsky, S., Rodin, S., & Domogatskaya, A. (2015) · Stem Cells International · doi:10.1155/2015/167025 · Cited by 200
“For ESC culture expansion (self-renewal) fibronectin, vitronectin, laminin-111, and laminin-111 containing basement membrane extract namedMatrigel, laminin-511 and laminin521 were successfully implemented [149–153].”
MethodTeratomas from pluripotent stem cells: A clinical hurdle
Fong, C., Gauthaman, K., & Bongso, A. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22775 · Cited by 222
“, 2002], and the use of serumfree and animal-free culture media [Ludwig et al., 2006] have helped tremendously in producing clinical grade hESCs for human applications.”
BackgroundLou, Y.-R., Kanninen, L., Kuisma, T., Niklander, J., Noon, L. A., Burks, D., Urtti, A., & Yliperttula, M. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0314 · Cited by 211
“Conventionally, the cells were cultured on feeder cells [1], and later, the Matrigel coating [4] was introduced to replace the feeder cells in combination with the use of conditioned medium or chemically defined medium, for example, mTeSR1 medium [5].”
Li, L., Bennett, S. A. L., & Wang, L. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.19583 · Cited by 207
Zhou, J., Su, P., Wang, L., Chen, J., Zimmermann, M., Genbacev, O., Afonja, O., Horne, M. C., Tanaka, T., Duan, E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901854106 · Cited by 204
Bone tissue engineering with human stem cells
Marolt, D., Knezevic, M., & Vunjak-Novakovic, G. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt10 · Cited by 207
“In recent years, progress has been made, and completely defi ned feeder-free conditions have been reported [ 65 ].”
BackgroundComparison of defined culture systems for feeder cell free propagation of human embryonic stem cells
The International Stem Cell Initiative Consortium, Akopian, V., Andrews, P. W., Beil, S., Benvenisty, N., Brehm, J., Christie, M., Ford, A., Fox, V., Gokhale, P. J., et al. (2010) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-010-9297-z · Cited by 208
“From this analysis, eight different culture systems (Li et al. 2005; Vallier et al. 2005; Liu et al. 2006; Lu et al. 2006; Ludwig et al. 2006a, b; Yao et al. 2006; Wang et al. 2007) were selected for further study by consortium laboratories.”
BackgroundMethodInfluentialSelf-citationDefined culture conditions of human embryonic stem cells
Lu, J., Hou, R., Booth, C. J., Yang, S.-H., & Snyder, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601383103 · Cited by 200
Pluripotent Stem Cells Derived From Adult Human Testes
Golestaneh, N., Kokkinaki, M., Pant, D., Jiang, J., DeStefano, D., Fernandez-Bueno, C., Rone, J. D., Haddad, B. R., Gallicano, G. I., & Dym, M. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0347 · Cited by 202
Khademhosseini, A., Ferreira, L., Blumling, J., Yeh, J., Karp, J. M., Fukuda, J., & Langer, R. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.06.035 · Cited by 202
“More recently, improved feeder free conditions have been derived [16,17]; however, significant”
BackgroundYAP Induces Human Naive Pluripotency
Qin, H., Hejna, M., Liu, Y., Percharde, M., Wossidlo, M., Blouin, L., Durruthy-Durruthy, J., Wong, P., Qi, Z., Yu, J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.036 · Cited by 197
“The mTeSR medium was specifically developed for culture of human PSCs (Ludwig et al., 2006) and has been widely used.”
MethodAlginate Based Scaffolds for Cartilage Tissue Engineering: A Review
Farokhi, M., Jonidi Shariatzadeh, F., Solouk, A., & Mirzadeh, H. (2020) · International Journal of Polymeric Materials and Polymeric Biomaterials · doi:10.1080/00914037.2018.1562924 · Cited by 192
Nagaoka, M., Si-Tayeb, K., Akaike, T., & Duncan, S. A. (2010) · BMC Developmental Biology · doi:10.1186/1471-213x-10-60 · Cited by 193
Derivation of Human Embryonic Stem Cells from Developing and Arrested Embryos
Zhang, X., Stojkovic, P., Przyborski, S., Cooke, M., Armstrong, L., Lako, M., & Stojkovic, M. (2006) · STEM CELLS · doi:10.1634/stemcells.2006-0377 · Cited by 196
Chemically Defined Culture and Cardiomyocyte Differentiation of Human Pluripotent Stem Cells
Burridge, P. W., Holmström, A., & Wu, J. C. (2015) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg2103s87 · Cited by 184
“Also see McKernan and Watt (2013) and Marx (2015).”
BackgroundCell therapy and the safety of embryonic stem cell-derived grafts
Hentze, H., Graichen, R., & Colman, A. (2007) · Trends in Biotechnology · doi:10.1016/j.tibtech.2006.10.010 · Cited by 197
Generating a Non-Integrating Human Induced Pluripotent Stem Cell Bank from Urine-Derived Cells
Xue, Y., Cai, X., Wang, L., Liao, B., Zhang, H., Shan, Y., Chen, Q., Zhou, T., Li, X., Hou, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070573 · Cited by 183
“Next, we found that UCs could survive and grow in serum-free media mTeSR1 and E8 which were used to maintains human ES or iPS cells [21,22], albeit slower than in their optimal medium (Fig.”
BackgroundAlbumin-Associated Lipids Regulate Human Embryonic Stem Cell Self-Renewal
Garcia-Gonzalo, F. R., & Izpisúa Belmonte, J. C. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001384 · Cited by 182
Hollmann, E. K., Bailey, A. K., Potharazu, A. V., Neely, M. D., Bowman, A. B., & Lippmann, E. S. (2017) · Fluids and Barriers of the CNS · doi:10.1186/s12987-017-0059-0 · Cited by 189
“to BMECs Previous protocols to differentiate iPSCs to BMECs relied on seeding iPSCs at defined densities, expanding the cells in mTeSR media for 3 days [26], and differentiating the cells for 6 days in UM to immature BMECs [24, 25, 37, 39].”
Toward xeno-free culture of human embryonic stem cells
Mallon, B. S., Park, K.-Y., Chen, K. G., Hamilton, R. S., & McKay, R. D. G. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.12.014 · Cited by 177
Embryonic stem cells as a source of models for drug discovery
Pouton, C. W., & Haynes, J. M. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2194 · Cited by 186
“A considerable number of hESC lines have now been derived from the inner cell mass of pre-implantation-stage blastocysts, using either mouse or human feeder cells, and more recently using a chemically defined mediu”
MethodChen, Y., Tristan, C. A., Chen, L., Jovanovic, V. M., Malley, C., Chu, P.-H., Ryu, S., Deng, T., Ormanoglu, P., Tao, D., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01126-2 · Cited by 172
Human and mouse adipose-derived cells support feeder-independent induction of pluripotent stem cells
Sugii, S., Kida, Y., Kawamura, T., Suzuki, J., Vassena, R., Yin, Y.-Q., Lutz, M. K., Berggren, W. T., Izpisúa Belmonte, J. C., & Evans, R. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910172106 · Cited by 179
“For feeder-independent production of hADSderived hiPS cells, we also avoided exposure of adipose-derived hiPS cells to animal products, by deriving these cells in a defined medium that consists of recombinant protein sources and purified human material (14).”
BackgroundMethodSelf-citationJozefczuk, J., Drews, K., & Adjaye, J. (2012) · Journal of Visualized Experiments · doi:10.3791/3854 · Cited by 168
Roles of Integrins in Human Induced Pluripotent Stem Cell Growth on Matrigel and Vitronectin
Rowland, T. J., Miller, L. M., Blaschke, A. J., Doss, E. L., Bonham, A. J., Hikita, S. T., Johnson, L. V., & Clegg, D. O. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0328 · Cited by 181
Feeder Layer Cell Actions and Applications
Llames, S., García-Pérez, E., Meana, Á., Larcher, F., & del Río, M. (2015) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2014.0547 · Cited by 163
“The growth factor requirements of the ESC appear to have been elucidated.(19) Transcriptomic and protein analyses comparing supportive and nonsupportive human feeder cells for hESC, revealed that the supportive feeder cells also express higher levels of fibroblast growth factor-2 (FGF2), Gremlin 1 (a bone morphogeneti…”
BackgroundLong-term human pluripotent stem cell self-renewal on synthetic polymer surfaces
Brafman, D. A., Chang, C. W., Fernandez, A., Willert, K., Varghese, S., & Chien, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.08.007 · Cited by 178
“Much of the research carried out on hPSCs thus far has focused on soluble signals and their effects on hPSC self-renewal [3,5,36], thus providing a well-defined alternative combination of soluble factors to replace conditioned medium for hPSC expansion [1e8].”
BackgroundScalable culture and cryopreservation of human embryonic stem cells on microcarriers
Nie, Y., Bergendahl, V., Hei, D. J., Jones, J. M., & Palecek, S. P. (2009) · Biotechnology Progress · doi:10.1002/btpr.110 · Cited by 175
“Another enhancement to the hESC-microcarrier culture would be xeno-free and defined components for ECM and medium as desired for future clinical applications in regenerative medicine.(38) However preliminary studies with mTeSR1 medium in our lab (data not shown) showed low attachment and survival of hESCs on microcarr…”
BackgroundSelf-citationThe many faces of Pluripotency: in vitro adaptations of a continuum of in vivo states
Morgani, S., Nichols, J., & Hadjantonakis, A.-K. (2017) · BMC Developmental Biology · doi:10.1186/s12861-017-0150-4 · Cited by 174
Musah, S., Wrighton, P. J., Zaltsman, Y., Zhong, X., Zorn, S., Parlato, M. B., Hsiao, C., Palecek, S. P., Chang, Q., Murphy, W. L., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415330111 · Cited by 169
“For initial experiments, we used a defined hPS cell culture medium utilized for hPS cell self-renewal, mTeSR (24), supplemented with Y27632, a small-molecule inhibitor of Rho-associated protein kinase (ROCK) (25).”
MethodO'Connor, M. D., Kardel, M. D., Iosfina, I., Youssef, D., Lu, M., Li, M. M., Vercauteren, S., Nagy, A., & Eaves, C. J. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0801 · Cited by 169
“As indicated, in some experiments, cells cultured in mTeSR1 were plated onto Matrigel-coated plates in 2 ml of mTeSR1 medium [ 6 ] containing 10 M Y-27632 (Calbiochem, Gibbstown, NJ, http:// www.emdbiosciences.com) [18] for the first 24 hours and then cultured for a further 6 days in mTeSR1 medium without Y-27632.”
MethodTsutsui, H., Valamehr, B., Hindoyan, A., Qiao, R., Ding, X., Guo, S., Witte, O. N., Liu, X., Ho, C.-M., & Wu, H. (2011) · Nature Communications · doi:10.1038/ncomms1165 · Cited by 171
“HsF1-oCT4-GFP (p62 + 15) 43300 46,XY,i(17)(q10)[8]”
Claassen, D. A., Desler, M. M., & Rizzino, A. (2009) · Molecular Reproduction and Development · doi:10.1002/mrd.21021 · Cited by 162
“Several years ago, a serum-free medium, mTeSR1, was developed for culturing human ES cells without a feeder layer (Ludwig et al., 2006a; Ludwig et al., 2006b).”
BackgroundMethodAttachment and growth of human embryonic stem cells on microcarriers
Phillips, B. W., Horne, R., Lay, T. S., Rust, W. L., Teck, T. T., & Crook, J. M. (2008) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2008.07.1997 · Cited by 167
Metadata
- Authors
- Ludwig, T. E., Levenstein, M. E., Jones, J. M., Berggren, W. T., Mitchen, E. R., Frane, J. L., Crandall, L. J., Daigh, C. A., Conard, K. R., Piekarczyk, M. S., Llanas, R. A., & Thomson, J. A.
- Affiliations
- WiCell (US)
- University of Wisconsin–Madison (US)
- Corresponding author
- Thomson, James A
- Venue
- Nature Biotechnology
- Published
- 2006-01-01
- Volume
- 24
- Issue
- 2
- Pages
- 185-187
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2038723730
- Cited by
- 1,114
- References
- 15
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 20 · 2023: 25 · 2022: 26 · 2021: 28 · 2020: 31 · 2019: 31 · 2018: 34 · 2017: 48 · 2016: 39 · 2015: 55 · 2014: 65 · 2013: 80 · 2012: 85
- FWCI
- 43.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r24rr017721-04)
- U.S. Public Health Service (P20-GMO69981)
- National Center for Research Resources (R24-RR017721)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- human embryonic stem cells, defined culture conditions, basic fibroblast growth factor, recombinant growth factors, stem cell derivation, stem cell lines, serum-free culture
- MeSH terms
- Cell Differentiation, Cell Line, Cell Survival, Culture Media, Humans, Stem Cells, Cell Culture Techniques, Tissue Engineering, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.